Digital health case studyVenture Capital
Mapping the Real-World Evidence Landscape in China for an Investor Thesis
Client context: Digital health-focused venture investor
Strategic question
Is real-world evidence in China a defensible thesis, and which ventures are emerging as category leaders?
Approach
Using HealthTech Alpha, we mapped RWE-enabled ventures in China, assessed data provenance, clinical partnerships and commercial traction, and benchmarked the category against global comparables.
Strategic implication
Sharpened the investor’s RWE thesis with a traceable view of category depth, differentiation and white space in China.
